Literature DB >> 12916697

Auditory steady-state response thresholds of adults with sensorineural hearing impairments.

Anthony T Herdman1, David K Stapells.   

Abstract

This study evaluated the use of multiple auditory steady-state responses (ASSRs) to estimate the degree and configuration of behavioral audiograms of subjects with sensorineural hearing impairments. Place specificity of the multiple-ASSR method was also assessed. Multiple amplitude-modulated (77-105 Hz) tones (500, 1000, 2000 and 4000 Hz) were simultaneously presented to one ear. The results showed that, on average, multiple-ASSR thresholds were 14 +/- 13, 8 +/- 9, 10 +/- 10 and 3 +/- 10 dB above behavioral thresholds for 500, 1000, 2000 and 4000 Hz, respectively. Behavioral and multiple-ASSR thresholds were significantly correlated (r = 0.75-0.89). There were no significant differences between behavioral and multiple-ASSR measures of the audiogram configuration. In subjects with steep-sloping > or = 30 dB/ octave) hearing losses, multiple-ASSR thresholds did not underestimate behavioral thresholds revealing good place specificity. These results indicate that the multiple-ASSR method provides good estimates of the degree and configuration of hearing in individuals with sensorineural hearing impairments.

Entities:  

Mesh:

Year:  2003        PMID: 12916697     DOI: 10.3109/14992020309078343

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  16 in total

1.  [Auditory steady-state response. On the threshold of clinical usage?].

Authors:  R Mühler
Journal:  HNO       Date:  2004-09       Impact factor: 1.284

2.  Towards an optimal paradigm for intraoperative auditory nerve monitoring with auditory steady state responses.

Authors:  Stefan Rampp; Leonhard Rensch; Sebastian Simmermacher; Torsten Rahne; Christian Strauss; Julian Prell
Journal:  J Clin Monit Comput       Date:  2016-02-06       Impact factor: 2.502

3.  [Audiometric thresholds estimated by auditory steady-state responses. Influence of EEG amplitude and test duration on accuracy].

Authors:  R Mühler; T Rahne
Journal:  HNO       Date:  2009-01       Impact factor: 1.284

4.  Comparison of pure tone audiometry and auditory steady-state responses in subjects with normal hearing and hearing loss.

Authors:  Ali Ozdek; Mahmut Karacay; Guleser Saylam; Emel Tatar; Nurdan Aygener; Mehmet Hakan Korkmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

5.  Age-Related Changes in Processing Simultaneous Amplitude Modulated Sounds Assessed Using Envelope Following Responses.

Authors:  Aravindakshan Parthasarathy; Jesyin Lai; Edward L Bartlett
Journal:  J Assoc Res Otolaryngol       Date:  2016-02-23

6.  Validity of correction factors applied to auditory steady-state responses (ASSRs) in normal hearing adults in chartr EP system.

Authors:  Zahra Ghasemahmad; Saeid Farahani
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-21       Impact factor: 2.503

7.  Effect of anolytic nitrite concentration on electricity generation and electron transfer in a dual-chamber microbial fuel cell.

Authors:  Rongchang Wang; Xuehao Wang; Xinyi Zhou; Jiabin Yao
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-11       Impact factor: 4.223

Review 8.  [Intraoperative monitoring of cochlear nerve function during cerebello-pontine angle surgery].

Authors:  S Rampp; T Rahne; S K Plontke; C Strauss; J Prell
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

9.  Automatic audiometry using auditory steady-state response and sequential test strategy applied to volunteers with normal hearing.

Authors:  Tiago Zanotelli; Felipe Antunes; Eduardo Mazoni Andrade Marçal Mendes; Leonardo Bonato Felix
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-28       Impact factor: 2.503

10.  Auditory steady-state responses and clinical applications.

Authors:  Andrea Canale; Michelangelo Lacilla; Andrea Luigi Cavalot; Roberto Albera
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-24       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.